CCDC93 Activators
Chemical activators of CCDC93 can influence the protein's function in vesicle formation and trafficking through various biochemical pathways. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate CCDC93, thereby enhancing its role in vesicle dynamics. Similarly, Diacylglycerol (DAG), a byproduct of phospholipid hydrolysis, can also activate PKC leading to phosphorylation events that may include CCDC93. Forskolin, on the other hand, increases the levels of cyclic AMP (cAMP) by activating adenylate cyclase. The elevated cAMP can then activate protein kinase A (PKA), which may target CCDC93 for phosphorylation, influencing its function in vesicle trafficking. The ionophores Ionomycin and A23187 (Calcimycin) elevate intracellular calcium levels, activating calmodulin-dependent kinases that can phosphorylate a range of proteins, including CCDC93. This calcium-dependent pathway is critical for the regulation of vesicle formation and trafficking.
Other compounds such as Calyculin A and Okadaic Acid act through inhibition of protein phosphatases 1 (PP1) and 2A (PP2A). By preventing the dephosphorylation of proteins, these inhibitors can lead to the sustained activation of CCDC93 by keeping it in a phosphorylated state. Phosphatidylinositol 4,5-bisphosphate (PIP2) serves as a membrane-bound signaling molecule that can recruit and activate proteins involved in vesicle trafficking, which may include CCDC93. Sphingosine-1-phosphate (S1P) activates sphingosine kinase, influencing phospholipid signaling and possibly the activity of CCDC93. Fumonisin B1 alters sphingolipid metabolism, which can affect the lipid composition of membranes and thus the activity of CCDC93 in vesicle trafficking. Lastly, Brefeldin A disrupts the Golgi apparatus, which could change the trafficking pathways and require CCDC93 to adjust its activity in response to the altered vesicular transport routes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate protein kinase C (PKC), which is known to phosphorylate a wide range of target proteins. Given CCDC93's role in clathrin-coated vesicle formation, PKC-mediated phosphorylation can activate CCDC93, enhancing its function in vesicle formation and trafficking. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinases, which can phosphorylate proteins associated with vesicular trafficking, leading to the functional activation of CCDC93. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which prevents dephosphorylation of proteins. Inhibition of these phosphatases can result in the hyperphosphorylation and activation of CCDC93 involved in vesicle trafficking. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid inhibits PP1 and PP2A leading to increased phosphorylation within the cell. This can result in the enhanced phosphorylation and activation of CCDC93, promoting its function in vesicular trafficking. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DAG is a second messenger that activates PKC. Activation of PKC can lead to the phosphorylation of proteins involved in vesicle formation and trafficking, potentially enhancing the functional activity of CCDC93 in these processes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to alter the phosphorylation state of various proteins. It could potentially promote the phosphorylation state of CCDC93, thereby activating it and enhancing its role in vesicular trafficking and membrane dynamics. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as an ionophore for calcium, similar to Ionomycin. It can increase intracellular calcium, possibly leading to the activation of CCDC93 through calcium-dependent phosphorylation pathways involved in vesicle formation and trafficking. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P can activate sphingosine kinase, which in turn can influence phospholipid signaling and vesicular trafficking. Through these signaling pathways, S1P can activate CCDC93, contributing to its role in the formation and trafficking of vesicles. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Fumonisin B1 inhibits ceramide synthase, leading to changes in sphingolipid metabolism. This can affect membrane dynamics and potentially activate CCDC93 by altering the lipid environment crucial for vesicle trafficking processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the structure and function of the Golgi complex, which could lead to the redistribution of proteins and lipids necessary for vesicular trafficking. This redistribution may activate CCDC93 as it adapts to the altered vesicle trafficking pathways. | ||||||